Form 4 for ADMA ADMA BIOLOGICS, INC.
Accepted 2022-03-09 00:00:00 ET · period of report 2022-03-07 · accession 0001140361-22-008677 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-03-09 | 2022-03-07 | ADMA | KWON YOUNG | Dir | A - Grant | $0.00 | +26.6K | 226.6K | +13% | $0 |
| D | 2022-03-09 | 2022-03-07 | ADMA | KWON YOUNG | Dir | A - Grant | $0.00 | +53.2K | 53.2K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-07 | A | A | 26,586 | $0.00 | 226,586 | D | — | — | (F1) These shares represent restricted stock units ("RSUs") that will vest in two equal installments, on the six- and 12-month anniversaries of the grant date, becoming fully vested on the one-year anniversary of the grant date, subject to the reporting person's continued service as of the applicable vesting date. (F2) Includes (i) 26,586 RSUs granted on March 7, 2022 and reported on this Form 4, subject to vesting as set forth in footnote (1); and (ii) 200,000 shares of common stock owned by the reporting person. |
| 2 | Derivative | Employee Stock Option (right to buy) | 2022-03-07 | A | A | 53,172 | $0.00 | 53,172 | D | $1.67 · — to 2032-03-07 | 53,172 Common Stock | (F3) The options vest in 12 equal monthly installments, becoming fully vested on the one-year anniversary of the date of grant. |